These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Effect of tetracaine and glibenclamide on 45Ca2+ handling by isolated pancreatic islets.
    Author: Norlund L, Sehlin J.
    Journal: Br J Pharmacol; 1985 May; 85(1):127-32. PubMed ID: 3928005.
    Abstract:
    The 45Ca2+ uptake in beta-cell-rich ob/ob-islets was measured using the La3+ wash technique. Tetracaine (1 mM) markedly enhanced the 45Ca2+ net uptake (120 min) in the presence of 3 mM glucose, and at 7 and 20 mM glucose there were clear tendencies to dose-dependent increases with 0.1 to 1 mM tetracaine. Glibenclamide 1 microM to 0.2 mM, stimulated the 45Ca2+ net uptake in the presence of 3 mM glucose and 0.1 mM to 0.2 mM glibenclamide potentiated the uptake in the presence of 7 mM glucose. When the drugs were added for only a 10 min incubation period, glibenclamide, 1 microM to 0.2 mM, but not tetracaine (10 microM to 1 mM) increased the short-term uptake of 45Ca2+. After preincubation with either of the drugs, neither tetracaine (10 microM to 1 mM) nor glibenclamide (10 nM to 0.2 mM) had any effect on the short-term 45Ca2+ uptake. In islets incubated with 45Ca2+ and tetracaine and washed without La3+ the apparent net uptake of 45Ca2+ was reduced by 0.5 to 1 mM tetracaine both at 3 and 20 mM glucose. Tetracaine (0.5 mM) stimulated the 45Ca2+ efflux in the presence of 3 mM glucose. The results show that both drugs affected the Ca2+ handling. It is suggested that glibenclamide mainly increases Ca2+ influx by voltage-dependent pathways, whereas tetracaine, at certain concentrations, mobilizes Ca2+ from intracellular stores in the islet cells.
    [Abstract] [Full Text] [Related] [New Search]